Back to Search
Start Over
Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?
- Source :
-
Annals of Internal Medicine . 11/3/2009, Vol. 151 Issue 9, p668-669. 2p. - Publication Year :
- 2009
-
Abstract
- The article reflects on biologics' cost-effectiveness as first-line treatment of rheumatoid arthritis (RA). It is informed that the biologics are priced at the maximum level the market will bear. It is also said that the number of diseases, which can be treated with biologics has increased substantially.
Details
- Language :
- English
- ISSN :
- 00034819
- Volume :
- 151
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Annals of Internal Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 45590294
- Full Text :
- https://doi.org/10.7326/0003-4819-151-9-200911030-00013